Crinetics Pharmaceuticals, Inc.
For the period ended Jun 30, 2026. Filed Aug 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 3, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
Checking your notes…
EXHIBIT INDEX
| ExhibitNumber · Incorporated by Reference · FiledHerewith | ||||||
|---|---|---|---|---|---|---|
| Exhibit Description · Form · File No. · Exhibit · Filing Date | ||||||
| 2.1† | Agreement and Plan of Merger by and among Crinetics Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated and Clark Merger Sub, Inc., dated July 6, 2026. | 8-K | 001-38583 | 2.1* | 7/6/2026 | |
| 3.1 | Amended and Restated Certificate of Incorporation | 8-K | 001-38583 | 3.3 | 7/20/2018 | |
| 3.2 | Amended and Restated Bylaws | 8-K | 001-38583 | 3.1 | 12/12/2023 | |
| 4.1 | Specimen Stock Certificate Evidencing the Shares of Common Stock | S-1/A | 333-225824 | 4.1 | 7/9/2018 | |
| 10.1 | Independent Consultant Agreement, effective as of April 10, 2026, between Crinetics Pharmaceuticals, Inc. and Jeff Knight. | 8-K | 10.1 | 4/10/2026 | ||
| 31.1 | Certification of Chief Executive Officer pursuant to Rules 13(a)-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002 | X | ||||
| 31.2 | Certification of Chief Financial Officer pursuant to Rules 13(a)-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002 | X | ||||
| 32.1* | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002 | X | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | X | ||||
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | X | ||||
†Schedules and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be furnished supplementally to the SEC upon request.
*The certification attached as Exhibit 32.1 that accompanies this Report is not deemed filed with the SEC and is not to be incorporated by reference into any filing of Crinetics under the U.S. Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.